Danaher: Biotech Momentum, Cost Cuts And Valuation Re-Rating Should Drive Upside - Seeking Alpha
1 hour ago • Google News
Danaher Corporation (DHR)
US$ 186.81-5.54%
Price Chart
Key Statistics
Market Cap
$ 142.28B
P/E Ratio
38.45
Revenue (TTM)
$ 23.82B
Volume
5.6M
52W High
$ 280.22
52W Low
$ 170.73
Dividend Yield
0.64%
Beta
0.80
Technicals
50-Day MA
194.8198
200-Day MA
223.8125
52 Week High
280.2229
52 Week Low
170.7284
About DHR
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biote.
Employees
61000
Headquarters
Washington, DC
CEO
Mr. Steven M. Rales
Latest News
Sovran Advisors LLC Raises Stock Position in Danaher Corporation (NYSE:DHR) - MarketBeat
50 minutes ago • Google News
DHR Global Appoints Leader for Houston Office - Hunt Scanlon Media
3 days ago • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
32.72
Percentile: 65.84
Environmental Risk Score
4.13
Percentile: 1
Social Risk Score
17.73
Percentile: 1
Governance Risk Score
7.86
Percentile: 1
Controversy Level
ESG data provided by Sustainalytics, Inc.
DHR
Category Average
2Moderate Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg